ARTICLE | Clinical News
Lialda mesalamine regulatory update
July 25, 2011 7:00 AM UTC
Shire said FDA approved an sNDA for Lialda mesalazine delayed release tablets for the maintenance of remission of ulcerative colitis (UC). The 5-aminosalicylate (5-ASA) mesalamine using Multi-Matrix s...